Get started
Author

Damien Simoneau

Observed names: D Simoneau, D. Simoneau
OpenAlex ID: A5035401689
“Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy
2015 · Isabel Conceição, Alejandra González‐Duarte, et al. · Journal of the Peripheral Nervous System · 297
PDF
Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors
2002 · A M Roque-Afonso, C Feray, et al. · Gut · 119
PDF
Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study
2008 · Jacques Bonnet, R. McPherson, et al. · Clinical Therapeutics · 92
Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies
2013 · C. Eckmann, P. Montravers, et al. · Journal of Antimicrobial Chemotherapy · 82
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: A plea for implementation of early switch and early discharge criteria
2014 · Christian Eckmann, Wendy Lawson, et al. · International Journal of Antimicrobial Agents · 58
PDF
Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections
2014 · D. Nathwani, C. Eckmann, et al. · Clinical Microbiology and Infection · 51
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies
2013 · P. Montravers, M. Bassetti, et al. · Journal of Antimicrobial Chemotherapy · 35
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies
2013 · M. Bassetti, C. Eckmann, et al. · Journal of Antimicrobial Chemotherapy · 28
Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
2022 · C. Cristina Quarta, Marianna Fontana, et al. · Frontiers in Cardiovascular Medicine · 27
PDF
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
2013 · X. Guirao, M. Sanchez Garcia, et al. · Journal of Antimicrobial Chemotherapy · 26
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies
2013 · W. R. Heizmann, H. Dupont, et al. · Journal of Antimicrobial Chemotherapy · 21
Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe
2014 · Dilip Nathwani, Christian Eckmann, et al. · BMC Infectious Diseases · 19
PDF
Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
2022 · Marek Bolanowski, Zaina Adnan, et al. · Frontiers in Endocrinology · 15
PDF
The pharmacokinetics of dalbavancin in subjects with mild, moderate, or severe hepatic impairment
2008 · J Dowell, E Seltzer, et al. · Critical Care · 8
PDF
Burden of disease and unmet needs associated with scoliosis in neurofibromatosis type 1: a systematic literature review
2025 · Michelle Welborn, Anant Tambe, et al. · JBMR Plus · 6
PDF
Design of 3 multicenter, phase 3, randomized trials to evaluate efficacy and safety of the enzyme replacement therapy efzimfotase alfa in patients with hypophosphatasia (HICKORY, MULBERRY, CHESTNUT)
2025 · Dahir Kathryn M., Freitas Joao Dinis, et al. · Endocrine Abstracts · 1
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India
2022 · Nirmalkumar Choraria, Savita Rangarajan, et al. · Indian Journal of Hematology and Blood Transfusion · 1
PDF
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India
2022 · Nirmalkumar Choraria, Savita Rangarajan, et al. · Indian Journal of Hematology and Blood Transfusion · 1
PDF
Co112 Development of a Composite Endpoint in Hypophosphatasia to Optimize Cost-effectiveness Demonstration
2026 · Philippe Laramee, Zorana Zupan, et al. · Value in Health
Design of 3 multicenter, phase 3, randomized trials to evaluate efficacy and safety of the enzyme replacement therapy efzimfotase alfa in patients with hypophosphatasia (HICKORY, MULBERRY, CHESTNUT)
2026 · L Seefried, K M Dahir, et al. · Osteologie/Osteology
Pin1 a Bayesian Meta-analysis of the Efficacy of Six Antimicrobial Agents for Confirmed Staphylococcus Aureus Complicated Skin and Soft-tissue Infections (csstis)
2008 · JFS Logman, MJ Treur, et al. · Value in Health
Dalbavancin safety in the phase 2/3 clinical development program
2008 · E Seltzer, L Goldberg, et al. · Critical Care
PDF
Dalbavancin dosage adjustments not required for patients with mild to moderate renal impairment
2008 · J Dowell, E Seltzer, et al. · Critical Care
PDF
Po23-785 Ldl-c and Crp in Atorvastatin Treated Stable Coronary Artery Disease Patients: the Cap (comparative Atorvastatin Pleotropic) Effects Study Results
2007 · J. Bonnet, J. Davignon, et al. · Atherosclerosis Supplements
HBIG in patients liver transplanted with HBc positive donors
2000 · A.M. Roque Afonso, J.F. Emile, et al. · Journal of Hepatology
Works count: 27
Citation count: 887
H-index: 13
I10-index: 13
Year
Topic
Type